title: [Indapamide in the treatment of hypertension in diabetes].
abstract: The authors treated 20 diabetics (14 men and 6 women) in an open clinical trial with indapamide (Arifon, Zorka Co.) for a period of three months, using a morning dose of 2.5 mg. In 10 patients with hypertension stage I in all normalization of the systolic pressure below 18.6 kPa and diastolic pressure below 12 kPa was achieved. Treatment of patients with hypertension stage II was not adequate in 6 patients. In the course of treatment metabolic compensation of diabetes (type 1 or type 2) did not deteriorate. No changes in the blood lipid spectrum and mineral metabolism were recorded. Indapamide is an antihypertensive drug suitable for treatment of mild hypertension in diabetics as monotherapy.
authors: II. interní klinika lékarské fakulty MU, Brno.
authors: B
authors: B
authors: Podrouzková
authors: L
authors: L
authors: Klabusay
authors: J
authors: J
authors: Olsovský
mesh_terms: D048909:Diabetes Complications; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D007190:Indapamide / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged
chemical_list: D007190:Indapamide
vernacular_title: Indapamid v lécbĕ hypertenze u diabetikŭ.